mRNA-5671 encodes mutated KRAS to treat colorectal, NSCLC and pancreatic cancers induced by one of four of the most common cancer-driving KRAS mutations (G12D, G12V, G13D and G12C) (116, 117). Here, KRAS is linked to familial pancreatic carcinoma.